2 results for day: 29/04/2021Not what you're looking for? Search Again

Immune modulating drug affects Lyme disease test, delays diagnosis

In this episode, I will be discussing the case of a young woman with multiple sclerosis (MS), who had a delay in diagnosis of Lyme disease due to the effects of an immunosuppressive medication she was receiving.

B cell suppressive therapy led to a delayed diagnosis of Lyme disease

I will be discussing a 20-year-old girl with a 3 year history of multiple sclerosis treated with B cell suppressive therapy . She was prescribed two biological disease-modifying antirheumatic drug (DMARD). This article was written by Sjowall and colleagues in the journal Frontiers in Neurology. She was initially prescribed tocilizumab, marketed in the US as Actemra.   Tocilizumab is a monoclonal antibody blocks signals from IL-6 receptors them, is a monoclonal antibody against the interleukin-6 receptor. Tocilizumab can lower the ability of your immune system to fight infections. She was subsequently prescribed rituximab, sold under the ...